Eli Lilly secures EU approval for Alzheimer's drug Kisunla and gains FDA nod to breast cancer therapy Inluriyo.

Semaglutide (better known as Wegovy) may help people with obesity lose up to 25% of their body weight when used at a higher ...

The amount of absolute risk reduction from a statin in a person without known heart disease depends mostly on a person's ...

The FDA has approved phentermine hydrochloride USP 8 mg, a low-dose medication for adults with obesity that can be taken up to three times daily, KVK Tech, Inc. announced in a press release. The new ...

She says millions of adults in the U.S. could benefit from medications and ... Jones points out that health care providers also use a risk calculator to estimate a person's individual risk of heart ...

Digital products can provide a steady stream of income for all types of professions. Create your own website in 15 minutes and start making money online! Having a digital product is a great revenue ...

Oral semaglutide at a dose of 25 mg may provide an alternative treatment option to injectable semaglutide (2.4 mg) and higher-dose oral semaglutide (50 mg) for persons with overweight or obesity. In a ...

Specific amounts of these foods were "potentially neuroprotective for age-related brain atrophy," thanks to antioxidant ...

This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. Weight loss can be a challenge, even for those who eat ...

MADRID -- The high-dose inactivated influenza vaccine may reduce older people's risk of hospitalization for flu or pneumonia more than a standard-dose shot, according to two large open-label, ...

Paltusotine (Palsonify; Crinetics), a novel nonpeptide somatostatin receptor type 2 nonpeptide (SST2) agonist, was FDA approved for the treatment of acromegaly in adults who had an inadequate response ...